Monthly Archives: June 2020

Analysts Offer Insights on Healthcare Companies: Seattle Genetics (NASDAQ: SGEN) and Adverum Biotechnologies (NASDAQ: ADVM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Seattle Genetics (SGEN – Research Report) and Adverum Biotechnologies (ADVM – Research Report) with bullish sentiments. Seattle Genetics (SGEN) Leerink Partners analyst

A Director at Ampco-Pittsburgh (NYSE: AP) is Buying Shares

Today, a Director at Ampco-Pittsburgh (AP – Research Report), Carl Pforzheimer, bought shares of AP for $56.9K. Following this transaction Carl Pforzheimer’s holding in the company was increased by 78.86% to a total of $148.1K. This is Pforzheimer’s first Buy

The CFO of Urban One is Exercising Options

Today it was reported that the CFO of Urban One (UONE – Research Report), Peter Thompson, exercised options to sell 445,682 UONE shares at $1.89 a share, for a total transaction value of $1.53M. Following Peter Thompson’s last UONE Sell

Maxim Group Issues a Buy Rating on Achieve Life Sciences (ACHV)

In a report released today, Naureen Quibria from Maxim Group assigned a Buy rating to Achieve Life Sciences (ACHV – Research Report), with a price target of $2.00. The company’s shares closed last Tuesday at $0.39, close to its 52-week

Oppenheimer Keeps Their Buy Rating on Mediwound (MDWD)

Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Mediwound (MDWD – Research Report) today and set a price target of $7.00. The company’s shares closed last Monday at $2.67. According to TipRanks.com, DeGeeter is a 5-star analyst with an

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and ACADIA Pharmaceuticals (NASDAQ: ACAD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Teladoc (TDOC – Research Report) and ACADIA Pharmaceuticals (ACAD – Research Report) with bullish sentiments. Teladoc (TDOC) In a report released today,